CoreCap Advisors’s Annovis Bio ANVS Stock Holding History

CoreCap Advisors’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.91K	Hold	2,101	–	–	﹤0.01%	2355
2026 Q1	$4.68K	Buy	+2,101	New	+$5.76K	﹤0.01%	2187

Other funds holding ANVS

Sherry Group Mountain Home, Arkansas $102M AUM

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

GCM

Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

DPW

DiNuzzo Private Wealth Beaver, Pennsylvania $1.01B AUM 16.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CoreCap Advisors's ANVS Position: Q2 2026 in Review

CoreCap Advisors held its Annovis Bio (ANVS) position steady in Q2 2026 at 2,101 shares worth $3.91K. The position accounts for ﹤0.01% of the portfolio, ranked #2355.

CoreCap Advisors first reported a position in ANVS in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.68K in Q1 2026. 7 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

CoreCap Advisors held 2,101 shares of Annovis Bio worth $3.91K as of Q2 2026.
CoreCap Advisors left its Annovis Bio share count unchanged in Q2 2026.
Annovis Bio made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2355 holding.
CoreCap Advisors first reported a position in Annovis Bio in Q1 2026 and has held it in 2 quarters since.
CoreCap Advisors's Annovis Bio position peaked at $4.68K in Q1 2026.
7 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.